Wed, 22 June 2016
Healthcare: Intern Invasion: Answering Their Questions On Healthcare Costs, Regulatory Risk, and M&A
Insurers can make or break drug developers, politicians can derail profits, and tax inversions are dead in the water -- should investors avoid healthcare stocks? |